p21 Antikörper
CDKN1A
Reaktivität: Human
WB
Wirt: Kaninchen
Polyclonal
unconjugated
Produktnummer ABIN2148242
-
-
Target
Alle p21 (CDKN1A) Antikörper anzeigen
-
p21 (CDKN1A)
(Cyclin-Dependent Kinase Inhibitor 1A (p21, Cip1) (CDKN1A))
-
Reaktivität
-
Human
-
Wirt
-
Kaninchen
-
Klonalität
-
Polyklonal
-
Konjugat
-
Dieser p21 Antikörper ist unkonjugiert
-
Applikation
-
Western Blotting (WB)
-
Aufreinigung
-
p21Cip1 antibody was purified by immunoaffinity chromatography.
-
Immunogen
-
p21Cip1 antibody was raised in Rabbit using the peptide sequence around aa 143~147 (R-Q-T-S-M) derived from Human p21Cip1 as the immunogen.
-
Top Product
-
Discover our top product CDKN1A Primärantikörper
-
anti-Cyclin-Dependent Kinase Inhibitor 1A (p21, Cip1) (CDKN1A) (AA 21-100) antibody
CDKN1A
Reaktivität: Human, Maus, Ratte, Schaf
WB, ELISA, FACS, IHC (p), IF (cc), IF (p), ICC, IHC (fro)
Wirt: Kaninchen
Polyclonal
unconjugated
-
-
Applikationshinweise
-
WB: 1:500-1:1000
-
Beschränkungen
-
Nur für Forschungszwecke einsetzbar
-
-
Format
-
Liquid
-
Konzentration
-
Lot specific
-
Buffer
-
In liquid form PBS buffer (no MG2+ or Ca2+), pH 7.4, 150 mm NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Konservierungsmittel
-
Sodium azide
-
Vorsichtsmaßnahmen
-
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
-
Avoid repeated freeze/thaw cycles
-
Lagerung
-
-20 °C
-
Informationen zur Lagerung
-
Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.
-
-
Target
-
p21 (CDKN1A)
(Cyclin-Dependent Kinase Inhibitor 1A (p21, Cip1) (CDKN1A))
-
Andere Bezeichnung
-
p21Cip1 (CDKN1A Produkte)
-
Synonyme
-
CCND1 antikoerper, CDKN1A antikoerper, CAP20 antikoerper, CDKN1 antikoerper, CIP1 antikoerper, MDA-6 antikoerper, P21 antikoerper, SDI1 antikoerper, WAF1 antikoerper, p21CIP1 antikoerper, CDKI antikoerper, Cdkn1 antikoerper, Waf1 antikoerper, mda6 antikoerper, p21Cip1 antikoerper, p21WAF antikoerper, Cip1 antikoerper, UV96 antikoerper, p21 antikoerper, cip1 antikoerper, p16Xic2 antikoerper, sdi1 antikoerper, waf1 antikoerper, cap20 antikoerper, cdkn1 antikoerper, mda-6 antikoerper, p21cip1 antikoerper, si:ch1073-48m5.2 antikoerper, KRAS2 antikoerper, p21ras antikoerper, cyclin D1 antikoerper, cyclin dependent kinase inhibitor 1A antikoerper, cyclin-dependent kinase inhibitor 1A (P21) antikoerper, cyclin-dependent kinase inhibitor 1A antikoerper, cyclin-dependent kinase inhibitor 1A L homeolog antikoerper, cyclin-dependent kinase inhibitor 1 antikoerper, KRAS proto-oncogene, GTPase antikoerper, CCND1 antikoerper, CDKN1A antikoerper, Cdkn1a antikoerper, cdkn1a.L antikoerper, cki1 antikoerper, cdkn1a antikoerper, KRAS antikoerper
-
Pathways
-
p53 Signalweg, PI3K-Akt Signalweg, Zellzyklus, AMPK Signaling, Fc-epsilon Rezeptor Signalübertragung, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Mitotic G1-G1/S Phases, DNA Replication, Hepatitis C, Synthesis of DNA, Autophagie
-